Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy.

Journal: European urology
Published Date:

Abstract

BACKGROUND: Robot-assisted laparoscopic radical prostatectomy has become a widespread technique despite a lack of randomised trials showing its superiority over open radical prostatectomy.

Authors

  • Anna Wallerstedt
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Solna, Stockholm, Sweden. Electronic address: anna.wallerstedt@karolinska.se.
  • Stavros I Tyritzis
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Thordis Thorsteinsdottir
    Division of Clinical Cancer Epidemiology, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Faculty of Nursing, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Stefan Carlsson
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Johan Stranne
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Ove Gustafsson
    Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Jonas Hugosson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Anders Bjartell
    Department of Urology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Ulrica Wilderäng
    Division of Clinical Cancer Epidemiology, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • N Peter Wiklund
    Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Gunnar Steineck
    Division of Clinical Cancer Epidemiology, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Oncology and Pathology, Division of Clinical Cancer Epidemiology, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Eva Haglind
    Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.